0001888097-21-000001.txt : 20211014
0001888097-21-000001.hdr.sgml : 20211014
20211014113430
ACCESSION NUMBER: 0001888097-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211014
DATE AS OF CHANGE: 20211014
EFFECTIVENESS DATE: 20211014
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fleet Therapeutics, Inc.
CENTRAL INDEX KEY: 0001888097
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-416918
FILM NUMBER: 211322823
BUSINESS ADDRESS:
STREET 1: 6 TIDE STREET, SUITE C, LAB C
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-305-1825
MAIL ADDRESS:
STREET 1: 6 TIDE STREET, SUITE C, LAB C
CITY: BOSTON
STATE: MA
ZIP: 02110
D
1
primary_doc.xml
X0708
D
LIVE
0001888097
Fleet Therapeutics, Inc.
6 TIDE STREET, SUITE C, LAB C
BOSTON
MA
MASSACHUSETTS
02110
857-305-1825
DELAWARE
None
None
Corporation
true
2019
Deborah
Palestrant
6 Tide Street, Suite C, Lab C
Boston
MA
MASSACHUSETTS
02110
Executive Officer
Director
Other
Decline to Disclose
- 06b
false
2021-09-16
false
true
false
0
58100470
24100475
33999995
false
4
0
0
0
false
Fleet Therapeutics, Inc.
/s/ Deborah Palestrant
Deborah Palestrant
Chief Executive Officer
2021-09-30